FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Astellas Gets Approval for Menopause Drug

[ Price : $8.95]

FDA approves Astellas Pharmas Veozah (fezolinetant), an oral drug for treating moderate-to-severe vasomotor symptoms caused by men...

FDA Encourages Voluntary Device Shortage Notices

[ Price : $8.95]

Due to its authority having expired on 5/11 with the end of the Covid-10 public health emergency (PHE), FDA now urges medical devi...

FDA Eases Blood Donor HIV Recommendations

[ Price : $8.95]

FDA eases its recommendations for evaluating potential blood donors for HIV.

Cook Tracheostomy Introducer Recall is Class 1

[ Price : $8.95]

FDA says a Cook Medical 4/7 recall of a tracheostomy introducer is Class 1.

FDA OKs Rexulti for Alzheimers Agitation

[ Price : $8.95]

FDA approves an Otsuka Pharmaceutical and Lundbeck supplemental NDA for Rexulti (brexpriprazole) oral tablets for treating agitati...

More Groups, Experts Back KEI Ad Music Petition

[ Price : $8.95]

Three stakeholder groups and seven individuals call for FDA to promptly approve a Knowledge Ecology International 2020 petition to...

FDA Planning for Future Public Health Issues

[ Price : $8.95]

FDA commissioner Robert Califf and chief medical officer Hilary Marston describe ways the agency will be better able to address fu...

Paper on Artificial Intelligency/Machine Learning

[ Price : $8.95]

Federal Register notice: FDA releases a discussion paper entitled Using Artificial Intelligence (AI) and Machine Learning (ML) in ...

Hydrochlorothiazide Not Withdrawn Over Safety/Efficacy

[ Price : $8.95]

Federal Register notice: FDA determines that Roxane Laboratories hydrochlorothiazide oral solution was not withdrawn from sale due...

Sibel Health Infant Monitor Cleared

[ Price : $8.95]

FDA clears a Sibel Health 510(k) on the ANNE One platform for continuous neonatal and infant monitoring.